Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America

Author:

Offen Walter,Chuang-Stein Christy,Dmitrienko Alex,Littman Gary,Maca Jeff,Meyerson Laura,Muirhead Robb,Stryszak Paul,Baddy Alex,Chen Kun,Copley-Merriman Kati,Dere Willard,Givens Sam,Hall David,Henry David,Jackson Joseph D.,Krishen Alok,Liu Thomas,Ryder Steve,Sankoh A. J.,Wang Julia,Yeh Chyon-Hwa

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Drug guides,Pharmacology (nursing)

Reference28 articles.

1. Hsu JC. Multiple Comparisons—Theory and Methods. Chapman and Hall: London, UK: 1996.

2. Sankoh AJ, Huque MF, Dubey SD. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med. 1997;16:2529–2542.

3. ICH E9. Statistical Principles for Clinical Trials. Step 5 guidance document, 2000. Available at: http://www.ich.org. Accessed November 11, 2006.

4. CPMP/EWP/908/99. Points to consider on multiplicity issues in clinical trials (adopted September 2002). Available at: http://www.emea.cu.int/pdfs/human/ewp/090899en.pdf. Accessed November 11, 2006.

5. Berger RL, Multiparameter hypothesis testing and acceptance sampling. Technometrics. 1982; 24:295–300.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3